Home > Financial Ratios > AARTI DRUGS

AARTI DRUGS
Core EBITDA Growth

    Back to All Ratios
AARTI DRUGS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -5.634.24-9.38-22.7066.63

What is the latest Core EBITDA Growth ratio of AARTI DRUGS ?

The latest Core EBITDA Growth ratio of AARTI DRUGS is -5.63 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-5.63
Mar20244.24
Mar2023-9.38
Mar2022-22.70
Mar202166.63

How is Core EBITDA Growth of AARTI DRUGS Trending?

Years Core EBITDA Growth % Change
Mar2025 -5.63
Negative
Mar2024 4.24
Positive
Mar2023 -9.38
Negative
Mar2022 -22.7
Negative
Mar2021 66.63 -

Other Financial Ratios of AARTI DRUGS


Compare Core EBITDA Growth ratio of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹4,792.8 Cr 3.9% 9.9% -2.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,342.0 Cr 3.4% 1.3% -11.6% Stock Analytics
DIVIS LABORATORIES ₹164,555.0 Cr 2.4% 3.2% 11.9% Stock Analytics
CIPLA ₹127,259.0 Cr 1.8% 1.9% -5.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,898.0 Cr 2.8% -0.9% 3.3% Stock Analytics
DR REDDYS LABORATORIES ₹110,394.0 Cr 1.7% 6.2% -0.3% Stock Analytics


AARTI DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

3.9%

9.9%

-2.6%

SENSEX

0.9%

1.2%

-0.4%


You may also like the below Video Courses